Welcome
About akampion
Professional approach
Services
Clients & case studies
News

News

Monday, 22. December 2025

Happy Holidays!

pin it
share
share
tweet
share
share

Mabylon AG Initiates Phase I Clinical Trial of Lead Compound MY006 for the Treatment of Peanut Allergy

Follow the Akampionieer

Mail us!
Subscribe to news updates
Follow us on twitter
Follow us on LinkedIn

Categories

Company News
Innovation Radar
Food for Thought
akampion Meets …

Archives

© akampion 2026 · all rights reserved ·

Imprint
Disclaimer
Privacy Policy

Welcome
About akampion
Professional approach
Services
Clients & case studies
News